Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott J Rodig

Showing results (131-140 of 293) with videos related to

Pageof 30
Sort By:
Cancer Research Communications|March 2, 2023
Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized LeukoplakiaGlenn J Hanna, Alessandro Villa, Nikhil Mistry, et al.
Cancer Research Communications|March 6, 2023
Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized LeukoplakiaGlenn J Hanna, Alessandro Villa, Nikhil Mistry, et al.
Nature Communications|August 29, 2024
Graph Fourier transform for spatial omics representation and analyses of complex organsYuzhou Chang, Jixin Liu, Yi Jiang, et al.
Blood Advances|January 4, 2018
Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunitiesElizabeth A Morgan, M Patrick Sweeney, Tamiwe Tomoka, et al.
Cancer Cell|June 15, 2013
SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomasLinfeng Chen, Stefano Monti, Przemyslaw Juszczynski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
The microenvironment of germ cell tumors harbors a prominent antigen-driven humoral responseSimon N Willis, Scott S Mallozzi, Scott J Rodig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1Przemyslaw Juszczynski, Scott J Rodig, Jing Ouyang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western populationScott J Rodig, Mari Mino-Kenudson, Sanja Dacic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2010
TIM-3: a novel regulatory molecule of alloimmune activationOlaf Boenisch, Francesca D'Addio, Toshihiko Watanabe, et al.
Blood|January 14, 2009
Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation modelsMelanie G Cornejo, Michael G Kharas, Miriam B Werneck, et al.
Pageof 30

Showing results (131-140 of 293) with videos related to

Sort By:
Pageof 30
Cancer Research Communications|March 2, 2023
Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized LeukoplakiaGlenn J Hanna, Alessandro Villa, Nikhil Mistry, et al.
Cancer Research Communications|March 6, 2023
Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized LeukoplakiaGlenn J Hanna, Alessandro Villa, Nikhil Mistry, et al.
Nature Communications|August 29, 2024
Graph Fourier transform for spatial omics representation and analyses of complex organsYuzhou Chang, Jixin Liu, Yi Jiang, et al.
Blood Advances|January 4, 2018
Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunitiesElizabeth A Morgan, M Patrick Sweeney, Tamiwe Tomoka, et al.
Cancer Cell|June 15, 2013
SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomasLinfeng Chen, Stefano Monti, Przemyslaw Juszczynski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
The microenvironment of germ cell tumors harbors a prominent antigen-driven humoral responseSimon N Willis, Scott S Mallozzi, Scott J Rodig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1Przemyslaw Juszczynski, Scott J Rodig, Jing Ouyang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western populationScott J Rodig, Mari Mino-Kenudson, Sanja Dacic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2010
TIM-3: a novel regulatory molecule of alloimmune activationOlaf Boenisch, Francesca D'Addio, Toshihiko Watanabe, et al.
Blood|January 14, 2009
Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation modelsMelanie G Cornejo, Michael G Kharas, Miriam B Werneck, et al.
Pageof 30